Immunological studies of reactive oxygen species damaged catalase in patients with systemic lupus erythematosus: Correlation with disease activity index

Immunological Investigations

Volumn 42, Issue 3, 2013, Pages 191-203

  Al Shobaili, Hani A ^a   Robaee, Ahmad A Al ^a   Alzolibani, Abdullateef A ^a   Rasheed, Zafar ^a  

^a QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Anti ROS CAT antibodies; Oxidized catalase; SLE; SLEDAI

Indexed keywords

CATALASE; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME MODIFICATION; ETHNIC AND RACIAL GROUPS; FEMALE; HUMAN; IMMUNOLOGICAL PROCEDURES; OXIDATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CATALASE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SEVERITY OF ILLNESS INDEX;

EID: 84874829148     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2012.751396     Document Type: Article

References (27)

1. Al-Shobaili, H. A., Al Robaee, A., Alzolibani, A., Khan, M. I., Rasheed, Z. 2011 Hydroxyl radical modification of immunoglobulin g generated cross-reactive antibodies its potential role in systemic lupus erythematosus. Clin. Med. Insights Arthritis Musculoskelet. Disord. 4 11-19.
2. Al-Shobaili, H. A., Al Robaee, A., Alzolibani, A. A., Rasheed, Z. 2012 Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms Role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE. Dis. Markers 3319-34.
3. Ghaly, M. S., Ghattas, M. H., Labib, S. M. 2012 Association of catalase gene polymorphisms with catalase activity and susceptibility to systemic lupus erythematosus in the Suez Canal area, Egypt. Lupus 21 1244-1249.
4. Goyal, M. M., Basak, A. 2010. Human catalase looking for complete identity. Protein Cell 1 888-897.
5. Hochberg, M. C. 1997 Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum. 40 1725-1734.
6. Hwang, I., Lee, J., Huh, J. Y., Park, J., Lee, H. B., Ho, Y. S., Ha, H. 2012 Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes 61 728-738.
7. Khan, M. F., Wu, X., Ansari, G. A. 2001 Anti-malondialdehyde antibodies in MRL/ mice treated with trichloroethene and dichloroacetyl chloride possible role of lipid peroxidation in autoimmunity. Toxicol. Appl. Pharmacol. 170s 88-92.
8. Levine, R. L., Wehr, N., Williams, J. A., Stadtman, E. R., Shacter, E. 2000 Determination of carbonyl groups in oxidized proteins. Meth. Mol. Biol. 99 15-24.
9. Mansour, R. B., Lassoued, S., Gargouri, B., El Gaid, A., Attia, H., Fakhfakh, F. 2008 Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand. J. Rheumatol. 37 103-108.
10. Manzi, S., Sánchez-Guerrero, J., Merrill, J. T., Furie, R., Gladman, D., Navarra, S. V.,Ginzler, E. M., D'Cruz, D. P., Doria, A., Cooper S., Zhong, Z. J., Hough, D., Freimuth,W., Petri, M. A. 2012 Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus combined results from two phase III trials. Ann. Rheum. Dis. 71 1833-1838.
11. Morgan, P. E., Sturgess, A. D., Hennessy, A., Davies, M. J. 2007 Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis. Free Radic. Res. 41 1301-1312.
12. Nadif, R., Mintz, M., Jedlicka, A., Bertrand, J. P., Kleeberger, S. R., Kauffmann, F. 2005 Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic. Res. 39 1345-1350.
13. Norheim, K. B., Jonsson, G., Harboe, E., Hanasand, M., Goransson, L., Omdal, R. 2012 Oxidative stress, as measured by protein oxidation, is increased in primary Sjøgren's syndrome. Free Radic. Res. 46 141-146.
14. Otaki, N., Chikazawa, M., Nagae, R., Shimozu, Y., Shibata, T., Ito, S., Takasaki, Y., Fujii,J., Uchida, K. 2010 Identification of a lipid peroxidation product as the source of oxidation-specific epitopes recognized by anti-DNA autoantibodies. J. Biol. Chem. 29 33834-33842.
15. Poon, H. F., Vaishnav, R. A., Gelchell, T. V., Getchell, M. L., Butterfield, D. A. 2006 Quantitative proteomics analysis of differential protein expression and oxidative modification of specific proteins in the brains of old mice. Neurobiol. Aging 27 1010-9.
16. Rasheed, Z. 2008 Hydroxyl radical damaged immunoglobulin G in patients with rheumatoid arthritis Biochemical and immunological studies. Clin. Biochem. 41 663-669.
17. Rasheed, Z., Ahmad, R., Rasheed, N., Ali, R. 2007 Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies. Autoimmunity 40 512-520.
18. Rasheed, Z., Ali, R. 2006 Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus Biochemical and immunological studies. Life Sci. 79 2320-2328.
19. Rasheed, Z., Al-Shobaili, H. A., Al Robaee, A. A., Alzolibani, A. A., Wadi, W. I., Khan,M. I., Al-Hamed, H. A. 2012 Preferential recognition of peroxynitrite damaged thymidine-monophosphate by Anti-DNA autoantibodies in systemic lupus erythematosus. Nucleosides Nucleotides Nucl. Acids 31 736-751.
20. Rasheed, Z., Al-Shobaili, H. A., Alzolibani, A. A., Ismail Khan, M., Ayub, T., Khan, M. I.,Rasheed, N. 2011 Immunological functions of oxidized human immunoglobulin G in type 1diabetes mellitus its potential role in diabetic smokers as a biomarker of elevated oxidative stress. Dis. Markers 31 47-54.
21. Rasheed, Z., Khan, M. W., Ali, R. 2006 Hydroxyl radical modification of human serum albumin generated cross reactive antibodies. Autoimmunity 39 479-488.
22. Schmid, F. X. 1997 Optical spectroscopy to characterize protein conformation and conformational changes. In Creighton, T. E. Ed., Protein Structure A Practical Approach. Oxford IRL Press, pp. 261-297.
23. Scofield, R. H., Kurien, B. T., Ganick, S., McClain, M. T., Pye, Q., James, J. A., Schneider,R. I., Broyles, R. H., Bachmann, M., Hensley, K. 2005. Modification of lupusassociated 60-KDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic. Biol. Med. 38 719-728.
24. Stadtman, E. R., Levine, R. L. 2000 Protein oxidation. Ann.NYAcad. Sci. 899 191-208.
25. Warchol, T., Lianeri, M., Wudarski, M., Lacki, J., Jagodzinski, P. 2008 Catalase -262C>T polymorphism in systemic lupus erythomatosus in Poland. Rheumatol. Int. 28 1035-1039.
26. Wiesik-Szewczyk, E., Lacki, J. K., Feleszko, W., Olesinska M. 2010 Target therapies in systemic lupus erythematosus current state of the art. Mini Rev. Med. Chem. 10956-65.
27. Zhang, Q., Ye, D. Q., Chen, G. P., Zheng, Y. 2010. Oxidative protein damage and antioxidant status in systemic lupus erythematosus. Clin. Exp. Dermatol. 35 287-294.